A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524)-Reference-Cited by-同舟云学术

A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524)

Published:2017-04 Issue:5 Volume:97 Page:995-1001
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Michaelson M. Dror,Hu Chen,Pham Huong T.,Dahl Douglas M.,Lee-Wu Chin,Swanson Gregory P.,Vuky Jacqueline,Lee R. Jeffrey,Souhami Luis,Chang Brian,George Asha,Sandler Howard,Shipley William

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference32 articles.

1. Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of RTOG protocol 85-12;Tester;Int J Radiat Oncol Biol Phys,1993

2. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: Results of Radiation Therapy Oncology Group phase II trial 8802;Tester;J Clin Oncol,1996

3. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: Initial results of Radiation Therapy Oncology Group 89-03;Shipley;J Clin Oncol,1998

4. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer;Zietman;J Urol,1998

5. The Initial Results in Muscle-Invading Bladder Cancer of RTOG 95-06: Phase I/II Trial of Transurethral Surgery Plus Radiation Therapy with Concurrent Cisplatin and 5-Fluorouracil Followed by Selective Bladder Preservation or Cystectomy Depending on the Initial Response

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and Predictive Roles of HER2 Status in Non-Breast and Non-Gastroesophageal Carcinomas;Cancers;2024-09-13

2. Terapia trimodal para el cáncer de vejiga: ¿es ahora el estándar para la enfermedad músculo-invasiva?;Actas Urológicas Españolas;2024-06

3. Is trimodal therapy the current standard for muscle-invasive bladder cancer?;Actas Urológicas Españolas (English Edition);2024-06

4. Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712;European Urology Oncology;2024-04

5. Organ preservation in muscle-invasive urothelial bladder cancer;Current Opinion in Oncology;2024-03-08